Histogen Inc.
HSTOQ
$0.027
-$0.003-10.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -99.50% | -99.56% | -99.56% | 265.21% | 150.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -99.50% | -99.56% | -99.56% | 265.21% | 150.50% |
| Cost of Revenue | -40.82% | -49.43% | -50.54% | -42.25% | -39.36% |
| Gross Profit | -84.23% | -34.12% | -4.26% | 83.66% | 76.81% |
| SG&A Expenses | -2.70% | 1.99% | 17.58% | 20.47% | 10.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.18% | -21.25% | -17.07% | -12.60% | -15.90% |
| Operating Income | -11.53% | -9.58% | -13.20% | 31.14% | 31.72% |
| Income Before Tax | -14.34% | -9.37% | -17.68% | 29.08% | 29.57% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.34% | -9.37% | -17.68% | 29.08% | 29.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -84.21% | -88.46% | -75.81% | -61.02% | -30.91% |
| Net Income | -14.69% | -9.83% | -18.19% | 28.96% | 29.57% |
| EBIT | -11.53% | -9.58% | -13.20% | 31.14% | 31.72% |
| EBITDA | -11.55% | -9.36% | -12.97% | 31.62% | 32.10% |
| EPS Basic | 32.63% | 41.38% | 26.93% | 55.95% | 63.06% |
| Normalized Basic EPS | 31.06% | 38.85% | 33.23% | 59.61% | 65.53% |
| EPS Diluted | 32.63% | 41.38% | 26.93% | 55.95% | 63.06% |
| Normalized Diluted EPS | 31.06% | 38.85% | 33.23% | 59.61% | 65.53% |
| Average Basic Shares Outstanding | 59.96% | 77.65% | 70.17% | 67.43% | 72.05% |
| Average Diluted Shares Outstanding | 59.96% | 77.65% | 70.17% | 67.43% | 72.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |